Annual Report

Overview

The report describes Gan & Lee Pharmaceuticals' 2020 performance, including RMB 3.362 billion of operating revenue and RMB 503 million invested in R&D. It records registration in 18 countries and commercial sales in 14 countries, reflecting the company's international expansion. The report also highlights approvals for new insulin products and a RMB 1 million donation supporting COVID-19 prevention and control.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2020
Period: 1 January 2020 – 31 December 2020
Language: English, Chinese
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services